Novel salt form of a dopamine agonist

Details for Australian Patent Application No. 2006211033 (hide)

Owner Pfizer Limited

Inventors Salingue, Fabrice Henri; Miller, Duncan Charles; Green, Stuart Peter; Lazzari, Olivier Alain

Agent Shelston IP

Pub. Number AU-A-2006211033

PCT Pub. Number WO2006/082511

Priority 0502509.3 07.02.05 GB

Filing date 26 January 2006

Wipo publication date 10 August 2006

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/5377 (2006.01)

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

C07C 309/25 (2006.01) Sulfonic acids

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/082511 Priority application(s): WO2006/082511

23 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006211037-Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof

2006211023-Fast wet-massing method for the preparation of calcium-containing compositions